Clinical Trial Update: Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating carboplatin as a radiosensitizer for childhood ependymoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Ependymoma | Phase 2 | Status: TERMINATED